New Once-Daily pill tested for rare copper disease
NCT ID NCT07010575
Summary
This study tested whether people with Wilson's Disease prefer a new once-daily medication over their current treatment that requires multiple daily doses. Ten adults who were already on stable treatment tried the new formulation for 28 days while reporting on their satisfaction and convenience. The goal was to see if the once-daily option improves treatment experience for this lifelong condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WILSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
VCTC
Hartshorne, Derbyshire, DE11 7AQ, United Kingdom
Conditions
Explore the condition pages connected to this study.